GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Humanigen Inc (FRA:0KB2) » Definitions » Purchase Of Investment

Humanigen (FRA:0KB2) Purchase Of Investment : €0.00 Mil (TTM As of Mar. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Humanigen Purchase Of Investment?

Humanigen's purchase of investment for the three months ended in Mar. 2023 was €0.00 Mil. It means Humanigen spent €0.00 Mil on purchasing investments. Humanigen's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2023 was €0.00 Mil.

Compared with last quarter (€0.00 Mil in Dec. 2022 ), Humanigen spent the same money on purchasing investments in Mar. 2023 (€0.00 Mil).

Humanigen Purchase Of Investment Historical Data

The historical data trend for Humanigen's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Humanigen Purchase Of Investment Chart

Humanigen Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Humanigen Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Humanigen Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Humanigen Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Humanigen's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Humanigen (FRA:0KB2) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Humanigen Inc (FRA:0KB2) » Definitions » Purchase Of Investment
Comparable Companies
MYMX RSPI RBSH KRBP CNBX EVFM PPCB CALA QBIO RGMP OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
HGENQ:USA
Address
830 Morris Turnpike, 4th Floor, Short Hills, NJ, USA, 07078
Website
https://www.humanigen.com
Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005. It has one segment, which is related to the development of pharmaceutical products.

Humanigen (FRA:0KB2) Headlines

No Headlines